Michael Brian Bell - Mar 1, 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell
Stock symbol
GH
Transactions as of
Mar 1, 2025
Transactions value $
-$107,949
Form type
4
Date filed
3/4/2025, 06:07 PM
Previous filing
Feb 4, 2025
Next filing
Mar 13, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +7.11K +21.42% $0.00 40.3K Mar 1, 2025 Direct
transaction GH Common Stock Tax liability -$108K -2.54K -6.3% $42.55 37.7K Mar 1, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Performance-Based Restricted Stock Units Options Exercise $0 -7.11K -33.33% $0.00 14.2K Mar 1, 2025 Common Stock 7.11K $0.00 Direct F2, F3
holding GH Performance-Based Restricted Stock Units 21.3K Mar 1, 2025 Common Stock 0 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027.
F3 Not applicable for Restricted Stock Units.